Cargando…

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model

BACKGROUND: Although increasing evidence has indicated that brain insulin dysfunction is a risk factor for Alzheimer disease (AD), the underlying mechanisms by which insulin deficiency may impact the development of AD are still obscure. Using a streptozotocin (STZ)-induced insulin deficient diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xu, Zheng, Wei, Xie, Jing-Wei, Wang, Tao, Wang, Si-Ling, Teng, Wei-Ping, Wang, Zhan-You
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987993/ https://www.ncbi.nlm.nih.gov/pubmed/21044348 http://dx.doi.org/10.1186/1750-1326-5-46

Ejemplares similares

Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
por: Devi, Latha, et al.
Publicado: (2012)

Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
por: Marazuela, Paula, et al.
Publicado: (2022)

Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis
por: Zhang, Zhi-Yuan, et al.
Publicado: (2013)

Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis
por: Yao, Yuemang, et al.
Publicado: (2004)

Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
por: Maarouf, Chera L, et al.
Publicado: (2013)

Vitamin A Deficiency Exacerbates Gut Microbiota Dysbiosis and Cognitive Deficits in Amyloid Precursor Protein/Presenilin 1 Transgenic Mice
por: Chen, Bo-Wen, et al.
Publicado: (2021)

Lysosomal-associated transmembrane protein 5 deficiency exacerbates cerebral ischemia/reperfusion injury
por: Zhang, Zongyong, et al.
Publicado: (2022)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
por: Wei, Zenghui, et al.
Publicado: (2021)

Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice
por: Luo, Min, et al.
Publicado: (2021)

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Ke, Yazi D., et al.
Publicado: (2009)

Enduring glucocorticoid-evoked exacerbation of synaptic plasticity disruption in male rats modelling early Alzheimer’s disease amyloidosis
por: Qi, Yingjie, et al.
Publicado: (2021)

Pre-plaque Aß-Mediated Impairment of Synaptic Depotentiation in a Transgenic Rat Model of Alzheimer’s Disease Amyloidosis
por: Qi, Yingjie, et al.
Publicado: (2019)

TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice
por: Devi, L, et al.
Publicado: (2015)

Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer’s disease related Aβ amyloidosis
por: Clark, Alexander T., et al.
Publicado: (2022)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease
por: Chen, Yijing, et al.
Publicado: (2020)

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
por: Laporte, Vincent, et al.
Publicado: (2006)

Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer’s mouse model are associated with hippocampal synaptic deficits in an age-dependent manner
por: Joseph, Donald J., et al.
Publicado: (2019)

Icariin Ameliorates Neuropathological Changes, TGF-β1 Accumulation and Behavioral Deficits in a Mouse Model of Cerebral Amyloidosis
por: Zhang, Zhi-Yuan, et al.
Publicado: (2014)

Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis
por: Karahan, Hande, et al.
Publicado: (2021)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022)

Impairments of Synaptic Plasticity Induction Threshold and Network Oscillatory Activity in the Hippocampus Underlie Memory Deficits in a Non-Transgenic Mouse Model of Amyloidosis
por: Mayordomo-Cava, Jennifer, et al.
Publicado: (2020)

Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease
por: Fu, Xin-Xin, et al.
Publicado: (2022)

FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
por: Bao, Xiu-Qi, et al.
Publicado: (2013)

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease
por: Bories, Cyril, et al.
Publicado: (2017)

Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia
por: An, Lulu, et al.
Publicado: (2021)

A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
por: Wang, Shao-wei, et al.
Publicado: (2017)

Lentivirus-Carried microRNA-195 Rescues Memory Deficits of Alzheimer’s Disease Transgenic Mouse by Attenuating the Generation of Amyloid Plaques
por: Su, Dan, et al.
Publicado: (2021)

Blast-Mediated Traumatic Brain Injury Exacerbates Retinal Damage and Amyloidosis in the APPswePSENd19e Mouse Model of Alzheimer's Disease
por: Harper, Matthew M., et al.
Publicado: (2019)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease
por: Liu, Yu-Hui, et al.
Publicado: (2021)

TRANSGENIC MOUSE MODELS OF ALZHEIMER’S DISEASE
por: Henry-Smith, Charnae A, et al.
Publicado: (2019)

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer’s Disease
por: Wang, Shengyuan, et al.
Publicado: (2015)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease
por: Jankowsky, Joanna L, et al.
Publicado: (2005)

Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease
por: Cao, Qing, et al.
Publicado: (2020)

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
por: Sykora, Peter, et al.
Publicado: (2015)

Systematic Review of the Relationship between Amyloid-β Levels and Measures of Transgenic Mouse Cognitive Deficit in Alzheimer’s Disease
por: Foley, Avery M., et al.
Publicado: (2015)

Polygalae Radix Extract Prevents Axonal Degeneration and Memory Deficits in a Transgenic Mouse Model of Alzheimer’s Disease
por: Kuboyama, Tomoharu, et al.
Publicado: (2017)

Hereditary and Sporadic Forms of Aβ-Cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models
por: Kumar-Singh, Samir
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v1phji2flu8mujthes1vpfdn53